Profound opiate toxicity in gastroparesis following therapeutic dose.

BMJ Case Rep

Department of Accident & Emergency, Broomfield Hospital, Chelmsford, UK.

Published: May 2016

Gastroparesis is defined by the presence of delayed gastric emptying without mechanical obstruction. Patients may present with severe discomfort that can mimic an acute abdomen including abdominal pain, vomiting, nausea, bloating, fullness and early satiety. The prevalence of gastroparesis is estimated at 24 per 100 000 and women are more commonly affected than men. It is associated with a number of conditions including diabetes, Parkinson's disease, multiple sclerosis, previous abdominal surgeries and connective tissue disorders, including scleroderma and Ehlers-Danlos syndrome. Drugs known to prolong gastric transit time, such as opiates, have been shown to exacerbate symptoms. We report a case of a 20-year-old woman with Ehlers-Danlos syndrome who developed respiratory depression after being administered a therapeutic dose of morphine. This occurred due to opiate toxicity confounded by gastroparesis. The patient required further support from intensive care until she recovered, and eventually underwent a gastric pacing procedure for symptomatic relief.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885361PMC
http://dx.doi.org/10.1136/bcr-2016-215308DOI Listing

Publication Analysis

Top Keywords

opiate toxicity
8
therapeutic dose
8
ehlers-danlos syndrome
8
profound opiate
4
gastroparesis
4
toxicity gastroparesis
4
gastroparesis therapeutic
4
dose gastroparesis
4
gastroparesis defined
4
defined presence
4

Similar Publications

Children are highly sensitive to toxins which can damage their organs and lead to death. Investigating the main causes of intoxication could reduce mortality and morbidity in children. In this cross-sectional study, the documents of all poisoned patients (214 cases) admitted to the emergency department of Taleghani children`s Hospital between April 2020 and 2023 were investigated.

View Article and Find Full Text PDF

Discovery of -Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma.

J Med Chem

January 2025

Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, and School of Pharmacy, East China University of Science and Technology, Shanghai 200237, P. R. China.

The search for new and effective chemotherapeutic agents for the treatment of glioblastoma (GBM) represents an unmet need in drug discovery. Herein, a class of novel -trifluoromethylated noscapines has been disclosed. Among them, 9'-bromo--trifluoromethyl noscapine displayed superior anti-GBM potency.

View Article and Find Full Text PDF

Revisiting opioid toxicity: Cellular effects of six commonly used opioids.

Scand J Pain

January 2024

The Beijer laboratory, Neuropharmacology and Addiction Research, Department of Pharmaceutical Biosciences, Uppsala University, SE-751 24, Uppsala, Sweden.

Objectives: There is an ongoing opioid crisis in the United States where the illicit and non-medical use of prescription opioids is associated with an increasing number of overdose deaths. Few studies have investigated opioid-induced effects on cell viability, and comparative studies are limited. Here, we examine the toxicity of six commonly used opioids: methadone, morphine, oxycodone, hydromorphone, ketobemidone, and fentanyl with respect to mitochondrial and membrane function .

View Article and Find Full Text PDF

Objective: Opioid toxicity continues to have significant morbidity and mortality in Alberta. Opioid agonist therapy is an effective treatment for opiate use disorder (OUD), with first-line treatment with buprenorphine-naloxone (BUP-NAL) being both highly effective and safe. Barriers to care limit access to treatment, and more access points for treatment are needed.

View Article and Find Full Text PDF

Outside-in hair contamination by blood containing opiates and opioids.

Forensic Sci Int

December 2024

CHRU-Nancy, Service de Pharmacologie Clinique et Toxicologie, Nancy F-54000, France; Université de Lorraine, CNRS, IMoPA, Nancy F-54000, France. Electronic address:

Hair analysis for drugs has become extensively used for forensic investigation in recent years. To best interpret hair drug content in post-mortem conditions, the extent of external contamination by biological fluids, such as blood, must be taken into account to avoid false positive results. The present study evaluated opiates and opioids incorporation into hair from blood containing different concentrations of morphine (MOR), 6-mono-acetyl morphine (6-AM), codeine (COD), dihydrocodeine (DHC), tramadol (TRA), oxycodone (OXY), methadone (MET), 2-ethylidene-1,5-dimethyl-3,3- diphenyl pyrrolidine (EDDP), buprenorphine (BUP) and norbuprenorphine (NBUP).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!